15% of Americans have ever taken the drugs, up from 6% in 2024.
A new Gallup poll found about 11% of Americans were taking a GLP-1 medication for weight loss.
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%.
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.
